Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000160

Chairperson & CEO sold 9,500 shares at an average $534.31 ($5,075,919)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

17 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-08 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-10-08 Sale : show line 2 in the form 10b5-1 −200 $525.50 $105,099 333,743 I
2026-10-08 Sale : show line 3 in the form 10b5-1 −767 $526.66 $403,951 332,976 I
2026-10-08 Sale : show line 4 in the form 10b5-1 −273 $527.57 $144,028 332,703 I
2026-10-08 Sale : show line 5 in the form 10b5-1 −200 $528.63 $105,725 332,503 I
2026-10-08 Sale : show line 6 in the form 10b5-1 −199 $530.13 $105,497 332,304 I
2026-10-08 Sale : show line 7 in the form 10b5-1 −1,061 $531.07 $563,468 331,243 I
2026-10-08 Sale : show line 8 in the form 10b5-1 −600 $532.07 $319,244 330,643 I
Open-market sales · 9,500 sh · avg $534.31 · $5,075,919

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-08 Exercise or conversion : show line 18 in the form 10b5-1 Stock Option −9,500 271,410 I
Loading xslF345X06/primarydocument.xml…